PINNA, ANNALISA
 Distribuzione geografica
Continente #
EU - Europa 58.293
NA - Nord America 2.158
AS - Asia 488
SA - Sud America 66
AF - Africa 11
Continente sconosciuto - Info sul continente non disponibili 3
Totale 61.019
Nazione #
IT - Italia 57.750
US - Stati Uniti d'America 2.145
CN - Cina 247
UA - Ucraina 173
SG - Singapore 161
SE - Svezia 125
DE - Germania 76
BR - Brasile 60
GB - Regno Unito 56
FI - Finlandia 43
FR - Francia 22
VN - Vietnam 22
HK - Hong Kong 18
BE - Belgio 13
KR - Corea 10
CA - Canada 9
IL - Israele 8
IN - India 8
NL - Olanda 8
CZ - Repubblica Ceca 6
RU - Federazione Russa 6
ES - Italia 5
MA - Marocco 4
BD - Bangladesh 3
EU - Europa 3
MX - Messico 3
PL - Polonia 3
AT - Austria 2
CH - Svizzera 2
CO - Colombia 2
DZ - Algeria 2
EG - Egitto 2
TH - Thailandia 2
VE - Venezuela 2
AR - Argentina 1
CL - Cile 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
IQ - Iraq 1
IR - Iran 1
JP - Giappone 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
MU - Mauritius 1
NO - Norvegia 1
PK - Pakistan 1
PT - Portogallo 1
TN - Tunisia 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 61.019
Città #
Cagliari 56.715
Uta 897
Fairfield 250
Chandler 238
Woodbridge 237
Ashburn 152
Ann Arbor 150
Wilmington 112
Seattle 111
Houston 96
Nyköping 96
Cambridge 91
Boardman 83
Jacksonville 81
Dearborn 71
Singapore 62
New York 57
Shanghai 51
Nanjing 38
Beijing 37
Santa Clara 30
Boston 26
Dong Ket 22
Helsinki 16
Hong Kong 16
Los Angeles 16
San Diego 14
Brussels 13
Milan 12
Council Bluffs 11
Rome 11
Guangzhou 10
Nanchang 10
Sassari 10
Seoul 10
Shenyang 10
Falls Church 9
Hebei 9
Frankfurt am Main 8
The Dalles 8
Toronto 8
Redwood City 7
Beersheba 6
Chicago 6
Jiaxing 6
Kunming 6
Mountain View 6
Oristano 6
Padova 6
Jinan 5
London 5
Munich 5
Norwalk 5
Pune 5
Grottammare 4
Sestu 4
São Paulo 4
Tianjin 4
Washington 4
Zhengzhou 4
Cracow 3
Essen 3
Florence 3
Hangzhou 3
Hefei 3
Kilburn 3
Madrid 3
Monopoli 3
Orange 3
Prague 3
Prescot 3
Rio de Janeiro 3
Atlanta 2
Auburn Hills 2
Baltimore 2
Bangkok 2
Bolzano 2
Camerino 2
Campo Grande 2
Caracas 2
Chengdu 2
Clifton 2
Dhaka 2
Düsseldorf 2
Edison 2
Gonnosfanadiga 2
Indiana 2
Monza 2
New Delhi 2
Nuoro 2
Nuremberg 2
Piscataway 2
Porto Alegre 2
Portsmouth 2
Shaoxing 2
Shenzhen 2
Taizhou 2
Verona 2
Wuhan 2
Xian 2
Totale 60.094
Nome #
Pharmacological characterization of 50-kHz ultrasonic vocalizations in rats: comparison of the effects of different psychoactive drugs and relevance in drug-induced reward 3.563
Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease 3.462
Dopaminergic neurodegeneration in a rat model of long-term hyperglycemia: preferential degeneration of the nigrostriatal motor pathway 2.945
Protective Agents in Parkinson's Disease: Caffeine and Adenosine A2A Receptor Antagonists 2.833
Role of adenosine A2A receptors in motor control: relevance to Parkinson’s disease and dyskinesia 2.692
Late-onset Parkinsonism in NFκB/c-Rel-deficient mice 2.643
Symptomatic and Neuroprotective Effects of A2A Receptor Antagonists in Parkinson’s Disease 2.587
Novel (Hetero)arylalkenyl propargylamine compounds are protective in toxin-induced models of Parkinson's disease 2.554
Dual target strategy: combining distinct non-dopaminergic treatments reduces neuronal cell loss and synergistically modulates l-DOPA-induced rotational behavior in a rodent model of Parkinson's disease 2.456
Assessment of symptomatic and neuroprotective efficacy of Mucuna pruriens seed extract in rodent model of Parkinson's disease 2.434
Lack of Rhes Increases MDMA-Induced Neuroinflammation and Dopamine Neuron Degeneration: Role of Gender and Age 2.384
The Small GTP-Binding Protein Rhes Influences Nigrostriatal-Dependent Motor Behavior During Aging 2.309
L-DOPA disrupts adenosine A(2A)-cannabinoid CB(1)-dopamine D(2) receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: Biochemical and behavioral studies 2.260
A critical evaluation of behavioral rodent models of motor impairment used for screening of antiparkinsonian activity: The case of adenosine A2A receptor antagonists 2.231
A new ethyladenine antagonist of adenosine A(2A) receptors: behavioral and biochemical characterization as an antiparkinsonian drug 2.031
Farmaci antiparkinsoniani ed attivi in altri disturbi motori 1.767
Behavioral, neurochemical, and electrophysiological changes in an early spontaneous mouse model of nigrostriatal degeneration 1.740
Caffeine consumption and changes in the function of dopaminergic transmission: evidence of a hyperdopaminergic state in rats subchronically treated with caffeine 1.727
Pharmacological therapy of Parkinson's disease: current options and new avenues 1.720
null 1.651
Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat 1.581
Antiparkinsonian actions and interactions of adenosine antagonists 1.563
Acute perinatal asphyxia impairs non-spatial memory and alters motor coordination in adult male rats 1.156
Adenosine A2A receptor antagonist treatment of Parkinson’s disease 1.109
Adenosine A2A receptor antagonists and Parkinson’s disease: state of the art and future directions 1.091
null 1.012
null 967
Protective Agents in Parkinson’s Disease: Caffeine and Adenosine A2A Receptor Antagonists 844
null 801
Fos expression induced by olanzapine and risperidone in the central extended amygdala 705
Characterization of Nasco grape pomace-loaded nutriosomes and their neuroprotective effects in the MPTP mouse model of Parkinson’s disease 636
Influence of Age and Genetic Background on Ethanol Intake and Behavioral Response Following Ethanol Consumption and During Abstinence in a Model of Alcohol Abuse 610
null 410
Farmaci antiparkinsoniani ed attivi in altri disturbi motori 405
Subchronic-intermittent caffeine amplifies the motor effects of amphetamine in rats 207
Extract from Nasco pomace loaded in nutriosomes exerts anti-inflammatory effects in the MPTP mouse model of Parkinson's disease 57
A2A Adenosine Receptor Antagonists and Their Efficacy in Rat Models of Parkinson’s Disease 28
Positive relation between dopamine neuron degeneration and metabolic connectivity disruption in the MPTP plus probenecid mouse model of Parkinson's disease 24
Early α-synuclein/synapsin III co-accumulation, nigrostriatal dopaminergic synaptopathy and denervation in the MPTPp mouse model of Parkinson's Disease 13
Totale 61.208
Categoria #
all - tutte 71.877
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.877


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020578 0 0 0 0 0 0 0 0 0 0 188 390
2020/202115.804 484 586 697 5.147 3.419 1.543 1.062 739 290 790 614 433
2021/20223.056 317 232 151 142 220 225 284 189 218 351 323 404
2022/20234.735 455 676 566 405 420 425 236 285 314 333 414 206
2023/20244.061 199 201 148 258 399 665 659 300 172 282 339 439
2024/20255.255 730 945 849 883 440 560 531 67 167 72 11 0
Totale 61.208